Antibody Design Labs (ADL) is a leading service provider in antibody discovery and engineering. ADL specializes in phage display with over 25 years of experience in the field. They are internationally-recognized for their ability to meticulously construct, and screen custom libraries of any format (peptide, Fab, scFv, single-domain). While ADL excels at traditional antibody discovery by immunization, naïve and peptide libraries are available for immediate and rapid screening. Additional available services include recombinant antibody production, engineering, and characterization and all work is accomplished in the US. Founded in 2011, ADL is committed to advancing recombinant antibody technologies and accelerating new and innovative discoveries.